INS and type 2 diabetes mellitus: In T2D patients, both a reduction in beta cell mass and impaired beta cell insulin secretory function have been observed [1,2,3]; however, whether the decrease in beta cell mass contributes to beta cell dysfunction or the dysfunction is secondary to decreased mass, is not clearly understood.